Jupiter Neurosciences, Inc. (JUNS) fundamentals score
and studies are reliable, Jupiter Neurosciences has not independently verified such data and it does not make any representation as to the accuracy of the
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 3.1 out of 10, Unhealthy fundamentals
- Growth: 3.5/10
- Profitability: 1.2/10
- Financial health: 2.2/10
- Earnings quality: 8.2/10
- Valuation: 1.5/10
Scores are calculated from Jupiter Neurosciences, Inc.’s SEC filings, using the 12 months through 2025-12. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10